Combating infectious diseases with synthetic biology

buir.contributor.authorKhan, Anooshay
buir.contributor.authorOstaku, Julian
buir.contributor.authorAras, Ebru
buir.contributor.authorSafak Seker, Urartu Ozgur
buir.contributor.orcidKhan, Anooshay|0000-0002-1577-2279
buir.contributor.orcidOstaku, Julian|0000-0002-3648-1112
buir.contributor.orcidAras, Ebru|0000-0002-6132-0601
buir.contributor.orcidSafak Seker, Urartu Ozgur|0000-0002-5272-1876
dc.citation.epage537en_US
dc.citation.issueNumber2en_US
dc.citation.spage528en_US
dc.citation.volumeNumber11en_US
dc.contributor.authorKhan, Anooshay
dc.contributor.authorOstaku, Julian
dc.contributor.authorAras, Ebru
dc.contributor.authorSafak Seker, Urartu Ozgur
dc.date.accessioned2023-02-15T11:42:41Z
dc.date.available2023-02-15T11:42:41Z
dc.date.issued2022-01-25
dc.departmentInstitute of Materials Science and Nanotechnology (UNAM)en_US
dc.departmentNanotechnology Research Center (NANOTAM)en_US
dc.description.abstractOver the past decades, there have been numerous outbreaks, including parasitic, fungal, bacterial, and viral infections, worldwide. The rate at which infectious diseases are emerging is disproportionate to the rate of development for new strategies that could combat them. Therefore, there is an increasing demand to develop novel, specific, sensitive, and effective methods for infectious disease diagnosis and treatment. Designed synthetic systems and devices are becoming powerful tools to treat human diseases. The advancement in synthetic biology offers efficient, accurate, and cost-effective platforms for detecting and preventing infectious diseases. Herein we focus on the latest state of living theranostics and its implications.en_US
dc.description.provenanceSubmitted by Mücahit Yazıcı (yazicimucahit300@gmail.com) on 2023-02-15T11:42:41Z No. of bitstreams: 1 Combating_infectious_diseases_with_synthetic_biology.pdf: 3151395 bytes, checksum: d2b2e1019b831e186fc7d05ba5ad7741 (MD5)en
dc.description.provenanceMade available in DSpace on 2023-02-15T11:42:41Z (GMT). No. of bitstreams: 1 Combating_infectious_diseases_with_synthetic_biology.pdf: 3151395 bytes, checksum: d2b2e1019b831e186fc7d05ba5ad7741 (MD5) Previous issue date: 2022-01-25en
dc.identifier.doi10.1021/acssynbio.1c00576en_US
dc.identifier.eissn2161-5063
dc.identifier.issn21615063
dc.identifier.urihttp://hdl.handle.net/11693/111344
dc.language.isoEnglishen_US
dc.publisherAmerican Chemical Societyen_US
dc.relation.isversionofhttps://dx.doi.org/10.1021/acssynbio.1c00576en_US
dc.source.titleACS Synthetic Biologyen_US
dc.subjectSynthetic biologyen_US
dc.subjectInfectious diseasesen_US
dc.subjectEngineered phage and bacteriaen_US
dc.subjectSARS-CoV-2en_US
dc.subjectDiagnosticsen_US
dc.subjectTherapeuticsen_US
dc.titleCombating infectious diseases with synthetic biologyen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Combating_infectious_diseases_with_synthetic_biology.pdf
Size:
3.01 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.69 KB
Format:
Item-specific license agreed upon to submission
Description: